Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Prince Fleet Easton Guests On “If These Walls Could Talk” With Hosts Wendy Stuart and Tym Moss Wednesday, November 25th, 2026

    November 22, 2026

    Faced with influx, prosecutor in Washington says he lacks resources to defend immigration cases

    November 22, 2026

    We lead MITs FutureTech program on the economics of AI: Dont ask if AI can do the job, ask how much it costs | Fortune

    November 22, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Science»The First Crispr Medicine Just Got Approved
    Science

    The First Crispr Medicine Just Got Approved

    By AdminNovember 17, 2023
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    The First Crispr Medicine Just Got Approved

    [ad_1]

    In sickle cell disease, abnormal hemoglobin makes a person’s blood cells hard and crescent-shaped. These misshapen cells clump together and block blood flow to organs, causing bouts of extreme pain. The cells then die off early, leaving a lack of healthy red blood cells, or anemia.

    Beta thalassemia also causes anemia because the body makes less hemoglobin than normal.

    People with life-threatening beta thalassemia need blood transfusions every three to five weeks and other medications throughout their lifetime.

    “Both sickle cell disease and beta thalassemia are painful, lifelong conditions that in some cases can be fatal,” said Julian Beach, interim executive director of healthcare quality and access at the UK’s MHRA, on Thursday.

    Casgevy is meant to restore working hemoglobin in the body. The therapy is not a traditional drug. Rather, it involves a complicated procedure. A patient’s stem cells are collected from their bone marrow and then sent to a lab for manufacturing. There, scientists use Crispr to make an edit in a gene that’s meant to turn on a functioning version of hemoglobin.

    Patients must then undergo a conditioning treatment to prepare their bone marrow to receive the modified cells. Afterward, they may need to spend a month or more in a hospital while the edited cells take up residence in the bone marrow and start to make healthy red blood cells.

    In a trial run by Vertex and Crispr Therapeutics, 45 patients have been treated with Casgevy but only 29 have been followed for at least 18 months. Of those, 28 were free of severe pain crises for at least a year after treatment.

    In a study of beta thalassemia patients, 54 patients have so far received Casgevy. Of 42 that have been followed long enough, 39 did not need a blood transfusion for at least a year after treatment. The remaining three had more than a 70 percent reduction in the need for transfusions. Side effects of the treatment include nausea, fatigue, fever, and increased risk of infection. Both trials are ongoing.

    Because Crispr is designed to permanently alter the genome, scientists think the effects could last for years, if not decades.

    Currently, sickle cell disease can be cured with a bone marrow transplant from a closely matched tissue donor, but only about 20 percent of patients have one. Transplants are also risky and may not work. They can cause a life-threatening complication in which the donor stem cells attack the recipient’s body.

    Vertex and Crispr Therapeutics have not announced a price for the therapy, but it’s likely to be expensive. Vertex says it is working closely with national health authorities in the US to secure access for eligible patients as quickly as possible.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleWhat to watch at home in November
    Next Article GM absorbs commercial EV unit BrightDrop, CEO is out

    RELATED POSTS

    Voyager 1 Beat the Odds and Is Still Working a Light-Day Away From Earth

    November 18, 2026

    The Dark Side of the Moon Was the Brightest Part of 2026

    November 17, 2026

    Just 400 US Data Centers Use More Electricity Than Michigan

    November 16, 2026

    The EPAs Chemical-Detecting Plane Isnt Doing Its Job Anymore

    November 16, 2026

    Its Getting Too Dry for Even Cactuses to Survive

    November 15, 2026

    New Species of Giant Fungus Discovered in China Grows up to 20 Inches Tall

    November 15, 2026
    latest posts

    Prince Fleet Easton Guests On “If These Walls Could Talk” With Hosts Wendy Stuart and Tym Moss Wednesday, November 25th, 2026

    Who else but hosts Wendy Stuart and Tym Moss could “spill the tea” on their weekly…

    Faced with influx, prosecutor in Washington says he lacks resources to defend immigration cases

    November 22, 2026

    We lead MITs FutureTech program on the economics of AI: Dont ask if AI can do the job, ask how much it costs | Fortune

    November 22, 2026

    Heres Where to Watch the Miami Dolphins vs. Buffalo Bills Game Live Online

    November 22, 2026

    Senate advances sweeping energy legislation in first major action since midterm elections

    November 22, 2026

    The Expedia breach shows why companies must stop holding data they do not need | Fortune

    November 22, 2026

    You Can See Everything review – stranger than fiction

    November 22, 2026
    Categories
    • Books (1,623)
    • Business (6,528)
    • Cover Story (18)
    • Film (6,462)
    • Lifestyle (4,502)
    • Music (6,538)
    • Politics (6,513)
    • Science (5,868)
    • Technology (6,465)
    • Television (6,160)
    • Uncategorized (3)
    • US News (6,511)
    popular posts

    The tech world mourns Susan Wojcicki

    [ad_1] Susan Wojcicki, a longtime Googler who spent nearly a decade as the CEO of…

    Varda Space puts off orbital factory reentry pending Air Force and FAA green light

    September 16, 2023

    Production Suspended on Netflix’s ‘The Chosen One’ After 2 Dead, 6 Injured in Car Crash

    June 18, 2022

    Mainboard Terminal Custom Computer Looks to be Straight from a Science Fiction Movie

    May 11, 2022
    Archives
    Browse By Category
    • Books (1,623)
    • Business (6,528)
    • Cover Story (18)
    • Film (6,462)
    • Lifestyle (4,502)
    • Music (6,538)
    • Politics (6,513)
    • Science (5,868)
    • Technology (6,465)
    • Television (6,160)
    • Uncategorized (3)
    • US News (6,511)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    The Expedia breach shows why companies must stop holding data they do not need | Fortune

    November 22, 2026

    You Can See Everything review – stranger than fiction

    November 22, 2026

    Luca Guadagnino Says His American Psycho Movie Not Moving Forward

    November 21, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT